report by Peter Doshi for the British Medical Journal has uncovered two high-ranking officials who worked for the FDA during the pandemic left the public sector position to work for Moderna. Dorian Fink, an employee of the FDA’s Office of Vaccines Research and Review, was part of the decision to license the COVID Pfizer and Moderna vaccines. He left the FDA in December 2022 and began working for Moderna two months later.

Jaya Goswami began working with the FDA’s Center for Biologics Evaluation and Research in March of 2020. She had “broad oversight over vaccines and biologics clinical development,” according to her. She also was tasked with determining whether Moderna’s vaccine clinical data met regulatory standards. Moderna was granted that license in January 2022. Goswami departed her position for the FDA in June 2022 to start working for Moderna as the Director of Clinical Development in Infectious Diseases.

Goswami has helped Moderna with the application for a new mRNA vaccine to prevent respiratory syncytial virus, which was submitted in July. The same office Goswami worked for at the FDA, the Office of Vaccines Research and Review, is responsible for reviewing this application.

Post-government employment regulations apply to all government agency employees seeking non-federal employment. 18 US Code 207(a)(1) states, “Former employees are subject to a lifetime ban on communicating to or appearing before the Government on behalf of their new employer or anyone else regarding specific party matters in which they participated personally and substantially during their entire government service.”

Despite these regulations, the BMJ report states that the FDA doesn’t keep records on employees after they leave government positions. They have no procedure to ensure former employees are not taking positions with private companies they were once tasked with regulating. The regulations are self-enforced, meaning Goswami and Fink are responsible for making sure they don’t participate in matters pertaining to government agencies they directly worked for.

Craig Holman is a lobbyist for a consumer advocacy organization, Public Citizen. In the BMJ report, Holman said, “The revolving door is particularly abusive in agencies that have a huge flood of money going in. That’s a big problem with the FDA, especially with the pandemic and Operation Warp Speed”

Holman, as an agent of Public Citizen, submitted an ethics complaint regarding another egregious conflict of interest under President Trump. Moncef Slaoui resigned from the board of Moderna and sold $12 Million of Moderna stock to take a contract position as the co-lead of Operation Warp Speed. Slaoui retained $10 Million worth of stock in GlaxoSmithKline. GSK worked with Sanofi, and together they received $2.1 billion in taxpayer funding through the Operation Warp Speed program.

Slaoui was not a government employee but a contractor. The government employee regulations intended to prevent conflicts of interest do not apply to government contractors. Moderna, as of 2020, had never brought an mRNA product to market despite a decade of trying. With Stephen Hahn as the commissioner, the FDA authorized Moderna’s mRNA vaccine in December 2020. Stephen Hahn joined Flagship Pioneering in June of 2021 as the Chief Medical Officer. Flagship Pioneering is a primary investor of Moderna. Hahn is now labeled as a CEO-partner on the company’s website.

A report published September 2023 in Health Affairs found that 54 percent of CDC staff members went on to work for private pharmaceutical companies between the years of 2004 and 2020. The report also looked at the deparDepartmentealth and Human Services (HHS) and found 32% of their staff went on to work in the private sector of the same industry.

The revolving door between government regulatory agencies and the private companies they regulate has been well established. Scott Gottlieb left his position as the FDA commissioner only to accept a position on the board of Pfizer in less than three months.

In the broader context of conflicts of interest within government regulatory agencies, this isn’t the first time such concerns have been raised. ICAN Lead Attorney, Aaron Siri, Esq., notably discussed a historic cross-examination of leading vaccinologist, Dr. Kathryn Edwards, revealing her conflict of interest as an advisor to Pfizer while simultaneously sitting on Pfizer’s ‘Independent’ Data Safety Monitoring Board for the COVID-19 Vaccine.

Public Citizen, the advocacy group, continues to look for accountability and enforcement of government regulations that should prevent obvious conflicts of interest. Without tracking the former employees of these agencies, no enforcement mechanism can protect the interests of the people. The lack of enforcement ensures American citizens will not get honesty and transparency from government organizations, and the revolving door remains the supreme policy for government employees.

Published Thursday, November 16, 2023

Steven Middendorp

Steven Middendorp is an investigative journalist, musician, and teacher. He has been a freelance writer and journalist for over 20 years. More recently, he has focused on issues dealing with corruption and negligence in the judicial system. He is a homesteading hobby farmer who encourages people to grow their own food, eat locally, and care for the land that provides sustenance to the community.

Other Headlines

Coronavirus

Yale Study Finds Post-Vaccine Syndrome Shares Symptoms with Long COVID

A preprint study from Yale University researchers examined a condition known as post-vaccination syndrome. The study included 42 individuals with PVS and 22 without. Researchers observed elevated levels of spike proteins in the PVS group for 36 to 709 days because the time that lapsed since the last vaccination varied between participants. It is aContinue reading Yale Study Finds Post-Vaccine Syndrome Shares Symptoms with Long COVID

More news about Coronavirus

Health & Nutrition

Kennedy Announces New HHS Research Targeting Autism’s Environmental Triggers

HHS Secretary Robert F. Kennedy Jr. held a press conference on Wednesday discussing the results of a CDC study and the continued increase in autism. Kennedy explained that improved diagnostics cannot explain the rise, but it is also due to environmental factors. Secretary Kennedy further pledged that the agency will conduct and analyze existing researchContinue reading Kennedy Announces New HHS Research Targeting Autism’s Environmental Triggers

More news about Health & Nutrition

Vaccines

Cleveland Clinic Preprint: Flu Shot Recipients 27% More Likely to Catch Flu

The Cleveland Clinic published a preprint study that concluded that those who received the 2024/2025 flu vaccine were 27% more likely to get the flu than those who received the unvaccinated group. The study evaluated 53,402 employees for the Cleveland Clinic in Ohio. 82.1% of the employees received an influenza vaccine by the end ofContinue reading Cleveland Clinic Preprint: Flu Shot Recipients 27% More Likely to Catch Flu

More news about Vaccines

Science & Tech

23andMe Files for Chapter 11 Bankruptcy; Genetic Data of 15 Million Users at Risk of Sale

The genetic data of 15 million people will soon be for sale as 23andMe has filed for Chapter 11 bankruptcy. The attorneys general for California and New York issued consumer alerts to advise consumers to take action to protect their data. New York AG Rob Bonta said “There’s health insurance companies that are interested inContinue reading 23andMe Files for Chapter 11 Bankruptcy; Genetic Data of 15 Million Users at Risk of Sale

More news about Science & Tech

Environment

New Study Links GM Crops to Higher Pesticide Use, Defying Industry Claims

A new study published in the Journal of Agrarian Change finds that genetically modified (GM or GMO) seeds have led to substantial increases in the amount of pesticides used on agricultural crops. This directly contradicts the claims made by agrochemical companies like Bayer, who have funded studies showing that GM crops decrease pesticide and herbicideContinue reading New Study Links GM Crops to Higher Pesticide Use, Defying Industry Claims

More news about Environment

Policy

HHS and FDA Launch Plan to Eliminate Petroleum-Based Food Dyes in U.S. Products

HHS Secretary Robert F. Kennedy Jr. and FDA Administrator Marty Makary, MD, MPH, announced steps the FDA is taking to transition away from synthetic petroleum-based food dyes, which aligns with European countries. Secretary Kennedy talked about the negative health effects associated with these food dyes and vowed to make changes as part of his roleContinue reading HHS and FDA Launch Plan to Eliminate Petroleum-Based Food Dyes in U.S. Products

More news about Policy